13D/13G Filings - Terns Pharmaceuticals Inc. (TERN)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, 3, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-02-14
6:25 pm
Purchase
2024-12-31 13G Terns Pharmaceuticals, Inc.
TERN
Citadel Advisors LLC 3,465,307
4.100%
54,543increase
(+1.60%)
Filing
History
2025-02-14
4:15 pm
Purchase
2024-12-31 13G Terns Pharmaceuticals, Inc.
TERN
Schonfeld Strategic Advisors LLC 5,234,508
6.160%
5,234,508increase
(New Position)
Filing
History
2025-02-11
4:00 pm
Purchase
2024-12-31 13G Terns Pharmaceuticals, Inc.
TERN
Soleus Capital Master Fund, L.P. 8,142,500
9.600%
1,918,956increase
(+30.83%)
Filing
History
2025-02-05
5:28 pm
Purchase
2024-12-31 13G Terns Pharmaceuticals, Inc.
TERN
BLACKROCK INC
BLK
5,743,482
6.800%
1,044,711increase
(+22.23%)
Filing
History
2024-11-15
10:35 am
Sale
2024-09-30 13G Terns Pharmaceuticals, Inc.
TERN
Point72 Asset Management, L.P. 2,894,093
3.500%
-1,027,133decrease
(-26.19%)
Filing
History
2024-11-14
7:00 pm
Purchase
2024-09-30 13G Terns Pharmaceuticals, Inc.
TERN
Vivo Capital Fund VIII L.P. 4,597,243
5.400%
4,597,243increase
(New Position)
Filing
History
2024-11-14
5:51 pm
Sale
2024-09-30 13G Terns Pharmaceuticals, Inc.
TERN
Venrock Healthcare Capital Partners III L.P. 3,516,889
4.990%
-980,228decrease
(-21.80%)
Filing
History
2024-11-14
4:15 pm
Sale
2024-09-30 13G Terns Pharmaceuticals, Inc.
TERN
Fairmount Funds Management LLC 0
0.000%
-6,632,015decrease
(Position Closed)
Filing
History
2024-11-14
3:41 pm
Sale
2024-09-30 13G Terns Pharmaceuticals, Inc.
TERN
SUVRETTA CAPITAL MANAGEMENT, LLC 0
0.000%
-5,837,126decrease
(Position Closed)
Filing
History
2024-11-14
3:30 pm
Purchase
2024-09-30 13G Terns Pharmaceuticals, Inc.
TERN
Soleus Capital Master Fund, L.P. 6,223,544
7.300%
2,882,424increase
(+86.27%)
Filing
History
2024-11-08
2:17 pm
Unchanged
2024-09-30 13G Terns Pharmaceuticals, Inc.
TERN
BLACKROCK INC
BLK
4,698,771
5.600%
0
(Unchanged)
Filing
History
2024-11-05
4:15 pm
Sale
2024-09-30 13G Terns Pharmaceuticals, Inc.
TERN
Integrated Core Strategies (US) LLC 1,628,534
1.900%
-1,851,096decrease
(-53.20%)
Filing
History
2024-10-24
2:02 pm
Purchase
2024-09-30 13G Terns Pharmaceuticals, Inc.
TERN
BLACKROCK INC
BLK
4,698,771
5.600%
1,577,906increase
(+50.56%)
Filing
History
2024-09-16
8:29 pm
Unchanged
2024-09-12 13D Terns Pharmaceuticals, Inc.
TERN
ORBIMED ADVISORS LLC 7,562,971
9.000%
0
(Unchanged)
Filing
History
2024-07-22
4:18 pm
Purchase
2024-07-10 13G Terns Pharmaceuticals, Inc.
TERN
Citadel Advisors LLC 3,410,764
5.300%
3,410,764increase
(New Position)
Filing
History
2024-07-18
5:33 pm
Sale
2024-07-16 13D Terns Pharmaceuticals, Inc.
TERN
ORBIMED ADVISORS LLC 7,562,971
11.700%
-56,164decrease
(-0.74%)
Filing
History
2024-06-07
1:30 pm
Sale
2024-05-31 13G Terns Pharmaceuticals, Inc.
TERN
BLACKROCK INC
BLK
3,120,865
4.800%
-288,113decrease
(-8.45%)
Filing
History
2024-06-07
08:30 am
Purchase
2024-06-06 13G Terns Pharmaceuticals, Inc.
TERN
Soleus Capital Master Fund, L.P. 3,341,120
5.200%
3,341,120increase
(New Position)
Filing
History
2024-03-07
4:15 pm
Purchase
2024-03-06 13G Terns Pharmaceuticals, Inc.
TERN
Point72 Asset Management, L.P. 3,921,226
6.300%
3,921,226increase
(New Position)
Filing
History
2024-02-14
8:38 pm
Purchase
2023-12-31 13G Terns Pharmaceuticals, Inc.
TERN
Venrock Healthcare Capital Partners III L.P. 4,497,117
7.300%
789,226increase
(+21.29%)
Filing
History
Goto 0, 1, 2, 3, Next